loader
Please Wait
Applying Filters...

EuroAPI Header EuroAPI Header

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Technical details about Bexotegrast, learn more about the structure, uses, toxicity, action, side effects and more

    Client Email Product
    Menu

    Bexotegrast

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass

    With Fermion, start the journey of your innovative API.

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    2D Structure
    1. Also known as: Bexotegras, Bexotegras [inn], Pln-74809, Qcv154pft4, (2s)-4-(2-methoxyethyl-(4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butyl)amino)-2-(quinazolin-4-ylamino)butanoic acid, (s)-4-((2-methoxyethyl)(4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butyl)amino)-2-(quinazolin-4-ylamino)butanoic acid
    Molecular Formula
    C27H36N6O3
    Molecular Weight
    492.6  g/mol
    InChI Key
    CWOFQJBATWQSHL-DEOSSOPVSA-N
    FDA UNII
    QCV154PFT4
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    (2S)-4-[2-methoxyethyl-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butyl]amino]-2-(quinazolin-4-ylamino)butanoic acid
    2.1.2 InChI
    InChI=1S/C27H36N6O3/c1-36-18-17-33(15-5-4-8-21-12-11-20-7-6-14-28-25(20)31-21)16-13-24(27(34)35)32-26-22-9-2-3-10-23(22)29-19-30-26/h2-3,9-12,19,24H,4-8,13-18H2,1H3,(H,28,31)(H,34,35)(H,29,30,32)/t24-/m0/s1
    2.1.3 InChI Key
    CWOFQJBATWQSHL-DEOSSOPVSA-N
    2.1.4 Canonical SMILES
    COCCN(CCCCC1=NC2=C(CCCN2)C=C1)CCC(C(=O)O)NC3=NC=NC4=CC=CC=C43
    2.1.5 Isomeric SMILES
    COCCN(CCCCC1=NC2=C(CCCN2)C=C1)CC[C@@H](C(=O)O)NC3=NC=NC4=CC=CC=C43
    2.2 Other Identifiers
    2.2.1 UNII
    QCV154PFT4
    2.3 Synonyms
    2.3.1 Depositor-Supplied Synonyms

    1. Bexotegras

    2. Bexotegras [inn]

    3. Pln-74809

    4. Qcv154pft4

    5. (2s)-4-(2-methoxyethyl-(4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butyl)amino)-2-(quinazolin-4-ylamino)butanoic Acid

    6. (s)-4-((2-methoxyethyl)(4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butyl)amino)-2-(quinazolin-4-ylamino)butanoic Acid

    7. 2376257-44-0

    8. Butanoic Acid, 4-((2-methoxyethyl)(4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butyl)amino)-2-(4-quinazolinylamino)-, (2s)-

    9. (2s)-4-[2-methoxyethyl-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butyl]amino]-2-(quinazolin-4-ylamino)butanoic Acid

    10. Unii-qcv154pft4

    11. Schembl21329445

    12. Gtpl12108

    13. Us10793564, Compound 5

    14. Bdbm465216

    15. Pln-74809 [who-dd]

    16. Pln74809

    17. Us10793564, Compound 55

    18. Hy-137561

    19. Cs-0140405

    2.4 Create Date
    2018-12-16
    3 Chemical and Physical Properties
    Molecular Weight 492.6 g/mol
    Molecular Formula C27H36N6O3
    XLogP31.8
    Hydrogen Bond Donor Count3
    Hydrogen Bond Acceptor Count9
    Rotatable Bond Count14
    Exact Mass492.28488903 g/mol
    Monoisotopic Mass492.28488903 g/mol
    Topological Polar Surface Area113 Ų
    Heavy Atom Count36
    Formal Charge0
    Complexity655
    Isotope Atom Count0
    Defined Atom Stereocenter Count1
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    Post Enquiry
    POST ENQUIRY